ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för psilocybin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

51 träffar

Bibliografisk träff 2017-12-01

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.

Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR.

Clin Pharmacokinet · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1007/s40262-017-0540-6

Bibliografisk träff 2017-10-17

The relationships of classic psychedelic use with criminal behavior in the United States adult population.

Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z, Pavela G.

J Psychopharmacol · journal article · DOI 10.1177/0269881117735685

Bibliografisk träff 2017-10-13

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.

Sci Rep · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-017-13282-7

Bibliografisk träff 2017-10-11

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.

Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA.

J Psychopharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1177/0269881117731279

Bibliografisk träff 2017-09-01

Effect of Psilocybin on Empathy and Moral Decision-Making.

Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX.

Int J Neuropsychopharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1093/ijnp/pyx047

Bibliografisk träff 2017-08-25

Enzymatic Synthesis of Psilocybin.

Fricke J, Blei F, Hoffmeister D.

Angew Chem Int Ed Engl · research support, non-u.s. gov't; journal article · DOI 10.1002/anie.201705489

Bibliografisk träff 2017-07-25

Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.

Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR.

Front Psychol · research-article; journal article · DOI 10.3389/fpsyg.2017.01238

Bibliografisk träff 2017-07-12

Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.

Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX.

Neuroimage · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.neuroimage.2017.07.020

Bibliografisk träff 2017-07-05

LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.

Larsen JK.

Nord J Psychiatry · journal article · DOI 10.1080/08039488.2017.1336251

Bibliografisk träff 2017-07-01

Potential Therapeutic Effects of Psilocybin.

Johnson MW, Griffiths RR.

Neurotherapeutics · review-article; review; journal article · DOI 10.1007/s13311-017-0542-y

Bibliografisk träff 2017-07-01

[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].

Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J.

Fortschr Neurol Psychiatr · review; journal article · DOI 10.1055/s-0043-103085

Bibliografisk träff 2017-06-07

Neuroticism is associated with challenging experiences with psilocybin mushrooms.

Barrett FS, Johnson MW, Griffiths RR.

Pers Individ Dif · research-article; journal article · DOI 10.1016/j.paid.2017.06.004

Bibliografisk träff 2017-06-01

Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.

Strauss N.

Med J Aust · journal article · DOI 10.5694/mja17.00081

Bibliografisk träff 2017-05-26

Psilocybin: Good Trip or Bad Trip.

Sellers EM.

Clin Pharmacol Ther · journal article · DOI 10.1002/cpt.697

Bibliografisk träff 2017-05-08

Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.

Thomas K, Malcolm B, Lastra D.

J Psychoactive Drugs · review; journal article · DOI 10.1080/02791072.2017.1320734

Bibliografisk träff 2017-04-26

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Carhart-Harris RL, Goodwin GM.

Neuropsychopharmacology · editorial; historical article; review; journal article · DOI 10.1038/npp.2017.84

Bibliografisk träff 2017-04-19

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.

Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep46421

Bibliografisk träff 2017-01-31

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.

Dinis-Oliveira RJ.

Drug Metab Rev · research support, non-u.s. gov't; review; journal article · DOI 10.1080/03602532.2016.1278228